Lanosterol

Lanosterol
Formula kimikoa	C30H50O
SMILES kanonikoa	2D eredua
SMILES isomerikoa	C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C
MolView	3D eredua
Konposizioa	karbono
Mota	Esterol eta [[(3S,10S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3S,10S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en)
Estereoisomeroa	(+)-tirucallol (en) , [[(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3S,5R,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3S,5R,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3R,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3R,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3S,5S,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3S,5S,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) , [[(3R,5R,10S,13S,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol\|(3R,5R,10S,13S,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol]] (en) eta Euphol (en)
Masa molekularra	426,386 Da
Erabilera
Rola	primary metabolite (en)
Identifikatzaileak
InChlKey	CAHGCLMLTWQZNJ-BQNIITSRSA-N
CAS zenbakia	79-63-0
ChemSpider	216175
PubChem	246983
Reaxys	2226449
Gmelin	16521
ChEMBL	CHEMBL225111
EC zenbakia	201-214-9
ECHA	100.001.105
CosIng	34865
MeSH	D007810
RxNorm	1442199
Human Metabolome Database	HMDB0001251
KNApSAcK	C00003657
UNII	1J05Z83K3M
KEGG	C01724
PDB Ligand	LAN

Lanosterola esterolen saileko alkohola da (C₂₈H₄₄O). Mutur batean daukan hidroxilo taldeari esker molekula anfipatikoa da.

Biosintesia

Eskualeno izeneko triterpenotik ekoizten da eta lanosterola oinarri hartuta eratzen dira gainerako esteroideak.

Eskualenoaren eta lanosterolaren ekoizpena.

Osasuna

Azken ikerketek erakutsi dute ugaztunetan begi-lausoa edo "katarata" sortzea ekiditen duela^[1].

Erreferentziak

↑ (Ingelesez) Zhang, Kang; Yan, Yong-Bin; Liu, Yizhi; Zhang, Liangfang; Wang, Jun; Sun, Xiaodong; Li, Yingrui; Granet, David et al.. (2015-07). «Lanosterol reverses protein aggregation in cataracts» Nature 523 (7562): 607–611. doi:10.1038/nature14650. ISSN 1476-4687. (Noiz kontsultatua: 2018-12-30).

Kanpo estekak

Datuak: Q414996
Multimedia: Lanosterol / Q414996

[1] (Ingelesez) Zhang, Kang; Yan, Yong-Bin; Liu, Yizhi; Zhang, Liangfang; Wang, Jun; Sun, Xiaodong; Li, Yingrui; Granet, David et al.. (2015-07). «Lanosterol reverses protein aggregation in cataracts» Nature 523 (7562): 607–611. doi:10.1038/nature14650. ISSN 1476-4687. (Noiz kontsultatua: 2018-12-30).

[1]